Wallace Werble, Jr.
This article was originally published in The Rose Sheet
Former F-D-C Reports publisher died Nov. 25 following a heart attack. He was 60. Werble, the son and namesake of F-D-C Reports Founding Editor & Publisher Wallace Werble, began his career with the company in 1968 and worked there until 1995. Following his father's death in 1976, Werble served as managing editor of "The Pink Sheet" before focusing exclusively on his role as publisher beginning in 1979. Among his accomplishments were the introduction of paid advertising, the transition to electronic publishing through third-party integrators and direct feeds to corporate networks, and live video broadcasts of FDA advisory committee meetings...
You may also be interested in...
This is an update of recommendations from the European Medicines Agency's Committee for Medicinal Products for Human Use on the authorization of new medicines in the European Union, and updates on EU marketing authorization changes recommended by the CHMP.
Sweden´s ecosystem for drug discovery and development is flourishing, seeded by academia, nurtured by incubators and funded from varied sources, 2020 report shows.
While Teva has helped to mitigate a Canadian shortage of salbutamol inhalers, Accord has struck a deal with the UK government to supply hydroxychloroquine. Sandoz is bolstering its inventory to meet demand and Apotex is donating critical medicines, while MedPharm’s new testing model will screen drugs for therapeutic eﬀectiveness and Beximco is focusing on manufacturing hydroxychloroquine, favipiravir and ivermectin.